AAAAAA

   
Results: 1-18 |
Results: 18
HEPATITIS-A VACCINATION - REPLY
Authors: NALIN DR
Citation: Dr. Nalin, HEPATITIS-A VACCINATION - REPLY, The New England journal of medicine, 339(10), 1998, pp. 705-705
SERUM ANTIBODIES TO HIV-1 ARE PRODUCED POST-MEASLES VIRUS-INFECTION -EVIDENCE FOR CROSS-REACTIVITY WITH HLA
Authors: BASKAR PV COLLINS GD DORSEYCOOPER BA PYLE RS NAGEL JE DWYER D DUNSTON G JOHNSON CE KENDIG N ISRAEL E NALIN DR ADLER WH
Citation: Pv. Baskar et al., SERUM ANTIBODIES TO HIV-1 ARE PRODUCED POST-MEASLES VIRUS-INFECTION -EVIDENCE FOR CROSS-REACTIVITY WITH HLA, Clinical and experimental immunology, 111(2), 1998, pp. 251-256
B-CELL MEMORY AFTER HEPATITIS-A VACCINATION, USING 2 OR 3 DOSES
Authors: CHEN XO DEGAST GC WANG RX BOLAND GJ NALIN DR VANHATTUM J
Citation: Xo. Chen et al., B-CELL MEMORY AFTER HEPATITIS-A VACCINATION, USING 2 OR 3 DOSES, Hepatology, 26(4), 1997, pp. 1215-1215
IMMUNOGENICITY OF 2 VERSUS 3 INJECTIONS OF INACTIVATED HEPATITIS-A VACCINE IN ADULTS
Authors: CHEN XQ BULBUL M DEGAST GC VANLOON AM NALIN DR VANHATTUM J
Citation: Xq. Chen et al., IMMUNOGENICITY OF 2 VERSUS 3 INJECTIONS OF INACTIVATED HEPATITIS-A VACCINE IN ADULTS, Journal of hepatology, 26(2), 1997, pp. 260-264
IMMUNOPRECIPITATION AND VIRUS NEUTRALIZATION ASSAYS DEMONSTRATE QUALITATIVE DIFFERENCES BETWEEN PROTECTIVE ANTIBODY-RESPONSES TO INACTIVATED HEPATITIS-A VACCINE AND PASSIVE-IMMUNIZATION WITH IMMUNE GLOBULIN
Authors: LEMON SM MURPHY PC PROVOST PJ CHALIKONDA I DAVIDE JP SCHOFIELD TL NALIN DR LEWIS JA
Citation: Sm. Lemon et al., IMMUNOPRECIPITATION AND VIRUS NEUTRALIZATION ASSAYS DEMONSTRATE QUALITATIVE DIFFERENCES BETWEEN PROTECTIVE ANTIBODY-RESPONSES TO INACTIVATED HEPATITIS-A VACCINE AND PASSIVE-IMMUNIZATION WITH IMMUNE GLOBULIN, The Journal of infectious diseases, 176(1), 1997, pp. 9-19
HEPATITIS-A VACCINE
Authors: NALIN DR
Citation: Dr. Nalin, HEPATITIS-A VACCINE, Journal of occupational and environmental medicine, 38(12), 1996, pp. 1200-1201
ANTIBODY PERSISTENCE AFTER PRIMARY MEASLES-MUMPS-RUBELLA VACCINE AND RESPONSE TO A 2ND DOSE GIVEN AT 4 TO 6 VS 11 TO 13 YEARS
Authors: JOHNSON CE KUMAR ML WHITWELL JK STAEHLE BO ROME LP DINAKAR C HURNI W NALIN DR
Citation: Ce. Johnson et al., ANTIBODY PERSISTENCE AFTER PRIMARY MEASLES-MUMPS-RUBELLA VACCINE AND RESPONSE TO A 2ND DOSE GIVEN AT 4 TO 6 VS 11 TO 13 YEARS, The Pediatric infectious disease journal, 15(8), 1996, pp. 687-692
DURATION OF PROTECTION FROM CLINICAL HEPATITIS-A DISEASE AFTER VACCINATION WITH VAQTA(R)
Authors: WIENS BL BOHIDAR NR PIGEON JG EGAN J HURNI W BROWN L KUTER BJ NALIN DR
Citation: Bl. Wiens et al., DURATION OF PROTECTION FROM CLINICAL HEPATITIS-A DISEASE AFTER VACCINATION WITH VAQTA(R), Journal of medical virology, 49(3), 1996, pp. 235-241
HEPATITIS-A VACCINES - REPLY
Authors: NALIN DR
Citation: Dr. Nalin, HEPATITIS-A VACCINES - REPLY, JAMA, the journal of the American Medical Association, 276(6), 1996, pp. 450-450
O COME, LET US WALLOW IN GLORIOUS MUD
Authors: NALIN DR
Citation: Dr. Nalin, O COME, LET US WALLOW IN GLORIOUS MUD, Transactions of the Royal Society of Tropical Medicine and Hygiene, 90(6), 1996, pp. 717-717
2-INJECTION VERSUS 3-INJECTION REGIMEN OF PURIFIED ALUM-ADJUVANTED INACTIVATED HEPATITIS-A VACCINE (VAQTA(TM)) IN HEALTHY-ADULTS VOL 45, PGA5, 1994)
Authors: CHEN XQ BULBUL M DEGAST GC VANLOON AM NALIN DR VANHATTUM J
Citation: Xq. Chen et al., 2-INJECTION VERSUS 3-INJECTION REGIMEN OF PURIFIED ALUM-ADJUVANTED INACTIVATED HEPATITIS-A VACCINE (VAQTA(TM)) IN HEALTHY-ADULTS VOL 45, PGA5, 1994), Netherlands journal of medicine, 46(1), 1995, pp. 56-56
LOW INCIDENCE OF ADVERSE EXPERIENCES AFTER MEASLES OR MEASLES-RUBELLAMASS REVACCINATION AT A COLLEGE CAMPUS
Authors: SEAGER C MORIARITY J NGAI A STAEHLE BO NALIN DR
Citation: C. Seager et al., LOW INCIDENCE OF ADVERSE EXPERIENCES AFTER MEASLES OR MEASLES-RUBELLAMASS REVACCINATION AT A COLLEGE CAMPUS, Vaccine, 12(11), 1994, pp. 1018-1020
HEPATITIS INFECTIONS IN THE DAY-CARE SETTING
Authors: HURWITZ ES DESEDA CC SHAPIRO CN NALIN DR FREITGKOONTZ MJ HAYASHI J
Citation: Es. Hurwitz et al., HEPATITIS INFECTIONS IN THE DAY-CARE SETTING, Pediatrics, 94(6), 1994, pp. 1023-1024
MEASLES-VACCINE IMMUNOGENICITY IN 6-MONTH-OLD VERSUS 15-MONTH-OLD INFANTS BORN TO MOTHERS IN THE MEASLES-VACCINE ERA
Authors: JOHNSON CE NALIN DR CHUI LW WHITWELL J MARUSYK RG KUMAR ML
Citation: Ce. Johnson et al., MEASLES-VACCINE IMMUNOGENICITY IN 6-MONTH-OLD VERSUS 15-MONTH-OLD INFANTS BORN TO MOTHERS IN THE MEASLES-VACCINE ERA, Pediatrics, 93(6), 1994, pp. 939-943
CHOLERA AND SEVERE TOXIGENIC DIARRHEAS
Authors: NALIN DR
Citation: Dr. Nalin, CHOLERA AND SEVERE TOXIGENIC DIARRHEAS, Gut, 35(2), 1994, pp. 145-149
2-INJECTION VS 3-INJECTION REGIMEN OF ALUM-ADJUVANTED INACTIVATED HEPATITIS-A VACCINE (VAQTA(R)) IN HEALTHY-ADULTS
Authors: CHEN XQ VANLOON AM DEGAST GC NALIN DR VANHATTUM J
Citation: Xq. Chen et al., 2-INJECTION VS 3-INJECTION REGIMEN OF ALUM-ADJUVANTED INACTIVATED HEPATITIS-A VACCINE (VAQTA(R)) IN HEALTHY-ADULTS, Gastroenterology, 106(4), 1994, pp. 10000875-10000875
SAFETY, TOLERABILITY, AND IMMUNOGENICITY OF AN INACTIVATED HEPATITIS-A VACCINE - EFFECTS OF SINGLE AND BOOSTER INJECTIONS, AND COMPARISON TO ADMINISTRATION OF IMMUNE GLOBULIN
Authors: SHOUVAL D ASHUR Y ADLER R LEWIS JA MILLER W KUTER B BROWN L NALIN DR
Citation: D. Shouval et al., SAFETY, TOLERABILITY, AND IMMUNOGENICITY OF AN INACTIVATED HEPATITIS-A VACCINE - EFFECTS OF SINGLE AND BOOSTER INJECTIONS, AND COMPARISON TO ADMINISTRATION OF IMMUNE GLOBULIN, Journal of hepatology, 18, 1993, pp. 190000032-190000037
WORLDWIDE EXPERIENCE WITH THE CR326F-DERIVED INACTIVATED HEPATITIS-A VIRUS-VACCINE IN PEDIATRIC AND ADULT-POPULATIONS - AN OVERVIEW
Authors: NALIN DR KUTER BJ BROWN L PATTERSON C CALANDRA GB WERZBERGER A SHOUVAL D ELLERBECK E BLOCK SL BISHOP R WIENS B SCHWARTZ SW LEWIS JA SITRIN RD PROVOST PJ MILLER WJ RYAN JL
Citation: Dr. Nalin et al., WORLDWIDE EXPERIENCE WITH THE CR326F-DERIVED INACTIVATED HEPATITIS-A VIRUS-VACCINE IN PEDIATRIC AND ADULT-POPULATIONS - AN OVERVIEW, Journal of hepatology, 18, 1993, pp. 190000051-190000055
Risultati: 1-18 |